Page last updated: 2024-08-22

indocyanine green and Epithelial Ovarian Cancer

indocyanine green has been researched along with Epithelial Ovarian Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Agusti, N; Díaz-Feijoo, B; Grillo-Ardila, C; Izquierdo, N; Paredes, P; Torne, A; Vidal-Sicart, S; Viveros-Carreño, D1
Buderath, P; Kimmig, R; Mach, P1
Bizzarri, N; Corrado, G; Cosentino, F; Fagotti, A; Ghezzi, F; Nero, C; Scambia, G; Turco, LC; Uccella, S; Vargiu, V; Vizza, E1
Dowdy, SC; Low, PS; Randall, LM; Tanyi, JL; Wenham, RM1
Buda, A; Bussi, B; Corrado, G; Cutillo, G; Magni, S; Passoni, P; Vizza, E1

Reviews

2 review(s) available for indocyanine green and Epithelial Ovarian Cancer

ArticleYear
Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 10-02, Volume: 33, Issue:10

    Topics: Carcinoma, Ovarian Epithelial; Coloring Agents; Female; Humans; Indocyanine Green; Lymph Node Excision; Lymph Nodes; Lymphadenopathy; Ovarian Neoplasms; Sentinel Lymph Node; Sentinel Lymph Node Biopsy

2023
The role of sentinel-node biopsy in ovarian cancer.
    Minerva ginecologica, 2020, Volume: 72, Issue:6

    Topics: Carcinoma, Ovarian Epithelial; Coloring Agents; Female; Humans; Indocyanine Green; Injections; Lymph Node Excision; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium

2020

Trials

3 trial(s) available for indocyanine green and Epithelial Ovarian Cancer

ArticleYear
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    American journal of obstetrics and gynecology, 2019, Volume: 221, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Coloring Agents; Feasibility Studies; Female; Humans; Indocyanine Green; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Pelvis; Preliminary Data; Prospective Studies; Retroperitoneal Space; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Time Factors

2019
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
    Gynecologic oncology, 2019, Volume: 155, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Coloring Agents; Cytoreduction Surgical Procedures; Female; Folate Receptor 1; Folic Acid; Humans; Indocyanine Green; Middle Aged; Ovarian Neoplasms; Prospective Studies; Spectroscopy, Near-Infrared; Surgery, Computer-Assisted

2019
Near-infrared Fluorescence-guided Sentinel Node Mapping of the Ovary With Indocyanine Green in a Minimally Invasive Setting: A Feasible Study.
    Journal of minimally invasive gynecology, 2017, 01-01, Volume: 24, Issue:1

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Indocyanine Green; Laparoscopy; Lymph Nodes; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Optical Imaging; Ovarian Neoplasms; Ovariectomy; Ovary; Sentinel Lymph Node Biopsy; Spectroscopy, Near-Infrared; Surgery, Computer-Assisted; Uterine Neoplasms

2017